Orchestra BioMed Holdings (OBIO) Shares Outstanding (Weighted Average) (2020 - 2026)

Orchestra BioMed Holdings (OBIO) has 7 years of Shares Outstanding (Weighted Average) data on file, last reported at $62.7 million in Q1 2026.

• Quarterly Shares Outstanding (Weighted Average) rose 8262.92% year-over-year to $62.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $62.7 million (up 8262.92% YoY) and the FY2025 annual result came in at $9.3 million, up 364.73% from the prior year.
• Shares Outstanding (Weighted Average) grew to $62.7 million in Q1 2026 per OBIO's latest filing, from $9.3 million in the prior quarter.
• Across five years, Shares Outstanding (Weighted Average) topped out at $62.7 million in Q1 2026 and bottomed at $750000.0 in Q1 2025.
• The 5-year median for Shares Outstanding (Weighted Average) is $6.1 million (2022), against an average of $15.3 million.
• The widest annual swing landed in 2025, when Shares Outstanding (Weighted Average) sank 94.25%; it then jumped 8262.92% in 2026.
• Tracing OBIO's Shares Outstanding (Weighted Average) over 5 years: stood at $1.3 million in 2022, then soared by 2403.65% to $33.2 million in 2023, then plunged by 93.99% to $2.0 million in 2024, then surged by 364.73% to $9.3 million in 2025, then jumped by 575.55% to $62.7 million in 2026.
• Per Business Quant, the three latest OBIO Shares Outstanding (Weighted Average) figures stand at $62.7 million (Q1 2026), $9.3 million (Q4 2025), and $9.3 million (Q3 2025).

Peer Comparison